Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

Varicella vaccine in the United States: a decade of prevention and the way forward.

Gershon AA, Arvin AM, Levin MJ, Seward JF, Schmid DS.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S39-40. doi: 10.1086/522165. No abstract available. Erratum in: J Infect Dis. 2008 Jun 15;197(12):1783.

PMID:
18419405
2.

Varicella zoster vaccines.

Creed R, Satyaprakash A, Ravanfar P.

Dermatol Ther. 2009 Mar-Apr;22(2):143-9. doi: 10.1111/j.1529-8019.2009.01226.x. Review.

PMID:
19335725
3.

Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.

Betts RF.

J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S143-7.

PMID:
18021866
4.

[Vaccination against herpes-zoster: a new strategy for post-herpetic neuralgia].

Gil de Miguel A.

An R Acad Nac Med (Madr). 2009;126(1):57-66; discussion 67-72. Spanish.

PMID:
20432659
5.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Rothberg MB, Virapongse A, Smith KJ.

Clin Infect Dis. 2007 May 15;44(10):1280-8. Epub 2007 Apr 3.

PMID:
17443464
6.

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Pellissier JM, Brisson M, Levin MJ.

Vaccine. 2007 Nov 28;25(49):8326-37. Epub 2007 Oct 17.

PMID:
17980938
7.

The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.

Edgar BL, Galanis E, Kay C, Skowronski D, Naus M, Patrick D.

Can Commun Dis Rep. 2007 Nov 1;33(11):1-15. English, French. No abstract available.

8.

[Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006].

García Cenoz M, Castilla J, Montes Y, Morán J, Salaberri A, Elía F, Floristán Y, Rodrígo I, Irisarri F, Arriazu M, Zabala A, Barricarte A.

An Sist Sanit Navar. 2008 Jan-Apr;31(1):71-80. Spanish.

PMID:
18496581
9.

Prevention and management of trigeminal herpes zoster and postherpetic neuralgia.

Closmann JJ, Fielding CG, Pogrel MA.

Gen Dent. 2008 Sep-Oct;56(6):563-6; quiz 567-8, 591-2.

PMID:
18810918
10.

Vaccination to prevent herpes zoster and postherpetic neuralgia.

Oxman MN.

Hum Vaccin. 2007 Mar-Apr;3(2):64-8. Epub 2007 Mar 23. Review. No abstract available.

PMID:
17299270
11.

Why should older adults receive the shingles vaccine?

Harkness TL.

J Gerontol Nurs. 2010 Oct;36(10):51-5. doi: 10.3928/00989134-20100504-06. Epub 2010 May 21.

PMID:
20506935
12.

[Modelling the impact of vaccination on the epidemiology of varicella zoster virus].

Bonmarin I, Santa-Olalla P, Lévy-Bruhl D.

Rev Epidemiol Sante Publique. 2008 Oct;56(5):323-31. doi: 10.1016/j.respe.2008.07.087. Epub 2008 Oct 31. French.

PMID:
18951741
13.

A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

Holcomb K, Weinberg JM.

J Drugs Dermatol. 2006 Oct;5(9):863-6. Review.

PMID:
17039651
14.

[Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].

[No authors listed]

MMW Fortschr Med. 2006;Spec no.1:14-5. German. No abstract available.

PMID:
16872127
15.

[Varicella vaccination: who should be vaccinated these days?].

Hügle B, Suchowerskyj P, Schuster V.

MMW Fortschr Med. 2005 Feb 24;147(8):31-2, 34-5. Review. German.

PMID:
18441563
16.

Varicella-zoster virus vaccine.

White CJ.

Clin Infect Dis. 1997 May;24(5):753-61; quiz 762-3. Review. No abstract available.

PMID:
9142766
17.
18.

Prevention of herpes zoster and its painful and debilitating complications.

Johnson R, McElhaney J, Pedalino B, Levin M.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S43-8. doi: 10.1016/S1201-9712(07)60021-6. Review.

19.

A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.

Carville KS, Riddell MA, Kelly HA.

Vaccine. 2010 Mar 16;28(13):2532-8. doi: 10.1016/j.vaccine.2010.01.036. Epub 2010 Jan 29.

PMID:
20117265
20.

Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.

Levin MJ, Schmader K.

Herpes. 2007 Sep;14 Suppl 2:45-7. Review.

PMID:
17939896

Supplemental Content

Support Center